New Paper Published: Plasma S100β is a Predictor for Pathology and Cognitive Decline in Alzheimer’s Disease

This study highlights plasma S100β as a promising non-invasive biomarker for early detection and progression monitoring of Alzheimer’s disease. Given its strong association with cognitive decline and AD pathology, S100β could serve as a valuable diagnostic tool, addressing the urgent need for accessible biomarkers to guide early interventions and treatment strategies.

View Publication

Recent Posts

Pannita achieves a perfect Bradford assay

Congratulations to Pannita on a perfect Bradford protein assay! This is a rare accomplishment, with only a few BHL members having achieved it over the years. Following a long-standing lab tradition, we celebrated Pannita’s perfect Bradford with a pizza party.

Read More »
October 19, 2026

From Brain Tissue to Barrier Function: Isolation of Brain Capillaries

Anika was invited to serve as an instructor at the 2026 CAJAL Course, “The Neurovascular Unit and Beyond – How CNS Border Sites Dynamically Regulate Brain Homeostasis” at the Bordeaux School of Neuroscience in Bordeaux, France. This intensive, two-week, hands-on course brings together early-career scientists from around the world to learn

Read More »
October 14, 2026